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Editor, Glioblastoma is the most common and most aggressive primary brain tumor. It usually spreads by direct extension and infiltration into the adjacent brain tissue and along with white matter tract rather than by metastasis. Extraneural metastasis from glioblastoma is rare despite the highly invasive nature with reported incidence of less than 2%. The rarity of this phenomenon has been attributed to various aspects of pathophysiology that prevent glioblastoma cells from infiltrating and surviving beyond the intra-cranial environment. We report a case of IDH-wild type glioblastoma with extracranial metastasis in submandibular region.
A 33-year-old male presented with headache, dizziness, and visual disturbance. The MRI brain showed irregular heterogenous mass in left temporal lobe. It measured 50 × 50 × 47 mm with necrotic and hemorrhagic areas and perifocal vasogenic edema [ Figure 1 ]. There was mass effect with left uncal herniation and rightward mild midline shift of 5 mm and ependymal enhancement of left lateral ventricle. Left temporal craniotomy and microsurgical total excision of left temporal tumor was done. Peroperatively, the tumor was non-encapsulated, heterogenous in color and texture, with areas of necrosis and hemorrhage. It was infiltrating into the left sylvian fissure and extending inferiorly up to left inferior cerebral artery. The microscopic examination revealed it to be pleomorphic astrocytic tumor with frequent mitosis, microvascular proliferation, and palisading necrosis [ Figure 2a ]. IHC showed GFAP [ Figure 2b ] and S-100 positivity [ Figure 2c ], whereas IDH-1 [R132H mutant] [ Figure 2d ], ATRX, synaptophysin were negative. The Ki-67 index was 30%. From histomorphology and IHC findings, the diagnosis made was glioblastoma, NOS, WHO grade IV. A subsequent IDH 1 and 2 gene mutation analysis by PCR-sequencing [tested for IDH1 -R132H,  R132C, R132S, R132G, R132L, R132V and IDH2 -R140G,  R140W, R140L, R140Q, R172K, R172G, R172M, R172W] did not show any mutation. He was further treated with chemotherapy (temozolomide) and radiotherapy. Two months post-radio therapy, he developed palpable mass in the left submandibular region. Fine-needle aspiration cytology (FNAC) was performed, and it showed sheets of partly degenerated tumor cells with abundant necrosis. Subsequently, trucut biopsy from submandibular mass showed mainly round to epithelioid cells with hyperchromatic nuclei along with foci of necrosis. On re-examination, the primary tumor also showed few foci with similar round to epithelioid cells [ Figure 3a and b]. It was interpreted as metastatic deposit of the glioblastoma, which was confirmed with IHC (GFAP positive, vimentin positive; cytokeratin, IDH-1, and ATRX negative). The MRI brain revealed recurrence/residual lesion in the temporal lobe. The patient was IDH-wild type glioblastoma is the most common and most malignant astrocytic glioma, accounting for 90% of all glioblastoma.
[1] IDH-wild type glioblastoma carry a significantly worse prognosis than IDH-mutant type glioblastoma. Glioblastoma has low potential to metastasize outside the confines of the central nervous system (CNS). The first documented metastatic glial tumor was described by Davis in 1928. [2] The extracranial metastases of glioblastoma are rare with a reported incidence of less than 2%. [2] Metastasis occurs most often in lung and pleura (found in 60% of patients with metastatic glioblastoma), regional lymph nodes (51%), bones (31%), and liver (22%). [3] Other targets for metastasis less commonly reported include operative flap, dural veins, meninges, scalp, kidney, spleen, adrenal gland, parotid gland, orbit, spleen, heart, and skin. [2] Among the lymph node metastasis, 62% were situated in cervical area and almost always occurs ipsilateral to the craniotomy but sometimes occur bilateral. [4] The various protective factors against the metastasis in glioblastoma include the absence of lymphatic vessels, action of blood brain barrier, the extremely shortened survival of patients, the dense connective tissue barrier of dura mater, the virtual absence of collagen, and fibronectin within the CNS parenchyma that would facilitate dissemination, lack of permissive stroma in other organs, poor affinity of glioma cells for arterial blood vessels, and lack of direct connection between subarachnoid space and the hematogenous or lymphatic system. [5] Despite the various protective factors, the extraneural metastasis is known. Lymph node metastases are commonly seen following surgery, especially craniotomies. This has lead to assumption that tumor cells gain access to the scalp lymphatics and vascular pathways during surgery. However, there are reports of metastasis in the absence of surgery.
Metastatic glioblastoma has been reported commonly in adult patients [with median age around 40 years], younger than in the typical elderly population of glioblastoma. Secondary glioblastoma also are more common in this younger population, and it is thought that the higher risk of metastasis may correspond to the longer duration of the tumor existence in these patients. [4] However, the index case is IDH-wild type glioblastoma, which typically arise de novo, with no recognizable lower grade precursor lesion. [1] The presence of extraneural metastasis of glioblastoma should be suspected if clinical history of primary CNS tumor is present. FNAC is a simple and reliable diagnostic method if such lesion is suspected from the history. [4] However, histomorphologic confirmation is mandatory in indeterminate cases. In general, histomorphology is similar to that observed in primary glioblastoma. [5] In the index case, there were foci of similar morphology in the primary and metastatic site. The neoplastic cells were negative for cytokeratin on IHC which helped in excluding a separate primary of salivary gland origin, which may also show Glial fibrillary acidic protein (GFAP) positivity.
The treatment of glioblastoma includes surgical excision of the primary tumor, followed by radiation therapy. Solitary and localized metastasis may be treated with surgical excision. Chemotherapy is frequently given in combination with radiation as an adjuvant treatment either before or after surgery. [5] Although several treatment approaches have been in clinical use, glioblastoma is still an aggressive tumor with unfavorable prognosis. Despite several theories to explain the mechanism of distant metastasis of GBM, the issue has not yet clarified. The diagnosis of extraneural metastasis has increased because of the improved survival from more radical surgery, better imaging studies, a higher index of suspicion, and improvement in adjuvant treatment. [5] To summarize, we report a case of IDH-wild type glioblastoma with extracranial metastasis in submandibular region. None of the previous reports or studies in metastatic glioblastoma mention about IDH mutation studies. Whether, the presence or absence of IDH mutation has any association on extracranial metastasis needs to be studied further.
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Multifocal recurrent conjunctival melanoma with diffuse primary acquired melanosis
Editor, Conjunctival malignant melanoma is a pigmented lesion of the ocular surface. It is an uncommon but potentially devastating tumour that may invade the local tissues of eye, spread systemically or recur inspite of treatment. In some cases, orbital exenteration is necessary.
A 64 year old Asian Indian female presented with a focal swelling and discolouration of left eyeball. The swelling was painless, was gradually increasing in size and did not interfere with the vision. There was a history of three small biopsies done outside. The biopsies from upper and lower eyelid showed melanocytic hyperplasia while the upper lid margin showed melanoma invading superficial subepithelial region. MRI of orbit done prior to the biopsies showed well defined complex mass lesion involving antero-medial aspect of left upper eyelid with no intraocular extension. The size of lesion on MRI measured 24 × 15 × 13 mm [ Figure 1a ]. Postbiopsy, patient had 8 × 8 mm brownish flat swelling of the lateral bulbar conjunctiva. Besides, there was fine brownish pigmentation of both upper and lower eyelid margins [ Figure 1b ]. In addition, there was induration in upper eyelid [site of previous biopsy]. The slit lamp examination of the anterior segment, intraocular pressure and indirect ophthalmoscopic examination of fundus were normal. The other eye on examination was normal. There was no enlargement of pre-auricular lymph nodes or any other lymph nodes in the neck. Systemic examination did not reveal any abnormality. Under topical anaesthesia, an excision of the conjunctival swelling was done.
Grossly, a single soft tissue piece measuring 1 × 0.8 × 0.5 cm was received. Microscopically, section showed single tissue fragment covered by partly eroded stratified squamous epithelium. The subepithelium showed sheets of oval to spindle cells. Cells display moderate nuclear pleomorphism along with prominent nucleoli and intracytoplasmic melanin pigment in some cells [ Figure 2a ]. Few mitotic figures were seen. Few entrapped lymphoid follicles were seen within the sheets of cells. The tumor appeared to be involving one of margins. The depth of lesion was maximum 5 mm. The other edge of biopsy showed intraepithelial clusters of atypical melanocytes [primary acquired melanosis with atypia]. The diagnosis of Conjunctival malignant melanoma was made.
During her next OPD visit, she presented with recurrent swelling at the previous conjunctival biopsy site. On PET CT there was no abnormal FDG uptake in the eyelid or elsewhere in the body. In view of multifocal recurrent melanoma and normal PET scan, left orbital exenteration was advised. Patient gave consent for the same. Grossly, the orbital exenteration specimen measured 4.5 × 4 × 3.5 cm. Optic nerve measured 1 cm in length. External examination revealed thickened indurated eyelids and fornix. In addition, the bulbar conjunctiva on lateral aspect showed greyish brown thickening measuring 0.8 × 0.6 cm. On slicing, the lesion was involving the conjuctiva only with unremarkable sclera and other internal structures.
Sections studied from lesion in bulbar conjunctiva (lateral to cornea) showed nests of atypical cells in subepithelium. The
